Shareholder Investigation Announced Against Kymera Therapeutics, Inc.
Purcell & Lefkowitz LLP has announced an investigation into Kymera Therapeutics, Inc. (NASDAQ: KYMR) on behalf of its shareholders. The firm is examining whether the company's directors breached their fiduciary duties in connection with recent corporate actions. The law firm invites affected shareholders to contact them for more information regarding potential legal options and rights. Purcell & Lefkowitz specializes in representing investors impacted by securities fraud or other forms of corporate misconduct.
Tickers: $KYMR
Topics: corporate governance fiduciary duties securities fraud